Abivax (ABVX) Short term Debt (2021 - 2025)

Abivax's Short term Debt history runs 5 years deep, the most recent figure standing at $1.5 million for Q4 2025.

• In Q4 2025, Short term Debt fell 96.84% year-over-year to $1.5 million; the TTM figure through Dec 2025 stood at $1.5 million (down 96.84% YoY), while the FY2025 annual figure was $1.5 million, down 96.84% from the prior year.
• Short term Debt was $1.5 million for Q4 2025 at Abivax, down from $34.4 million in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $57.1 million in Q2 2025 to a low of $1.5 million in Q4 2025.
• Historically, Short term Debt has averaged $31.7 million across 5 years, with a median of $34.4 million in 2025.
• The sharpest annual moves came in 2024 and 2025: Short term Debt soared 1171.82% in 2024, then tumbled 96.84% in 2025.
• A 5-year view of Short term Debt shows it stood at $13.0 million in 2021, then surged by 163.78% to $34.2 million in 2022, then sank by 88.97% to $3.8 million in 2023, then jumped by 1171.82% to $48.0 million in 2024, then sank by 96.84% to $1.5 million in 2025.
• The last three Short term Debt figures came in at $1.5 million (Q4 2025), $34.4 million (Q3 2025), and $57.1 million (Q2 2025), per Business Quant data.